Search - tctmd.com

Displaying 201 - 220 of 1726

Sort: Relevancy | Date

Presentation TCT 2023

Case 5: DCB in ACS

Presenter: Simon Eccleshall

October 25, 2023

Presentation TCT 2023

Case 3: DCB for Diffuse Disease (Stand Alone or Hybrid)

Presenter: Antonio Colombo

October 25, 2023

Presentation TCT 2023

Case 2: DCB for Small Vessel

Presenter: Sandeep Basavarajaiah

October 25, 2023

Presentation TCT 2023

Case 1: DCB for In-Stent Restenosis

Presenter: Rony Mathew

October 25, 2023

Presentation TCT 2023

Tips and Tricks on How to Use DCB for Coronary Interventions: Lesion Preparation, Adjunctive Devices, Dwell Time, and Beyond

Presenter: Roisin Colleran

October 25, 2023

Presentation TCT 2023

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

Presenter: Lawrence Garcia

October 25, 2023

Presentation TCT 2023

DCB Update: Overview of Current Clinical and Anatomical Indications

Presenter: Robert Byrne

October 25, 2023

Presentation TCT 2023

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Presenter: David Tryon

October 25, 2023

Presentation TCT 2023

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

Presenter: Alexandre Abizaid

October 25, 2023

Presentation TCT 2023

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Presenter: Stefan Verheye

October 25, 2023

News Conference News TCT 2022

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Yael L. Maxwell

September 27, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

September 19, 2022

Presentation TCT 2022

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

Presenter: Antonio Mangieri

September 19, 2022

Presentation TCT 2022

DynamX Bioadaptor and Desyne BDS+

Presenter: Alexandre Cunha Abizaid

September 19, 2022

Presentation TCT 2022

IoNir Hybrid Coronary DES System

Presenter: Haim Danenberg

September 19, 2022

Presentation TCT 2022

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Presenter: Michael Haude

September 19, 2022

Presentation TCT 2022

Drug Elution: Challenges and Opportunities

Presenter: Sahil Parikh

September 18, 2022

Presentation TCT 2022

Coronary DCB in HBR Patients: An Alternative to DES?

Presenter: Tuomas Rissanen

September 18, 2022

Presentation TCT 2022

Role of Drug-Eluting Technologies as Definitive Therapy

Presenter: Beau Hawkins

September 18, 2022

Advertisement

Case 5: DCB in ACS

Case 3: DCB for Diffuse Disease (Stand Alone or Hybrid)

Case 2: DCB for Small Vessel

Case 1: DCB for In-Stent Restenosis

Tips and Tricks on How to Use DCB for Coronary Interventions: Lesion Preparation, Adjunctive Devices, Dwell Time, and Beyond

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

DCB Update: Overview of Current Clinical and Anatomical Indications

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

DynamX Bioadaptor and Desyne BDS+

IoNir Hybrid Coronary DES System

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Drug Elution: Challenges and Opportunities

Coronary DCB in HBR Patients: An Alternative to DES?

Role of Drug-Eluting Technologies as Definitive Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content